Navigation Links
Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer

GSK Announces Launch of Largest Ever Phase III Clinical Trial in Lung Cancer Treatment

PHILADELPHIA, June 05, 2007 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced final results of a Phase II proof-of-concept clinical trial of its investigational MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) in MAGE-A3 positive patients with stage IB or II Non-Small Cell Lung Cancer (NSCLC). These data were presented at the 2007 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Illinois, [Abstract No: 7554]. Final trial analysis showed a 27% reduction in the relative risk of cancer recurrence following surgery in patients treated with the MAGE-A3 ASCI, compared to placebo.

"Final results from this trial confirm the positive interim results released last year at ASCO 2006, and support expanded testing of this novel cancer immunotherapy," said Paul A. Bunn Jr., M.D., James Dudley Endowed Professor of Oncology, Professor of Medicine and Director of the University of Colorado Cancer Center, Aurora, Colorado. "This approach represents a potentially momentous shift in the cancer treatment paradigm. I believe we have only just scratched the surface of what is possible and look forward to seeing the results of the Phase III trial in due course."

Based on these encouraging data, GSK also announced today the opening of patient recruitment to the randomized and controlled Phase III efficacy and safety trial for this novel cancer immunotherapy; the largest clinical trial ever conducted in lung cancer treatment. MAGE-A3 ASCI will be evaluated as adjuvant therapy in about 2,270 MAGE-A3 positive patients with completely resected stage IB, II or IIIA NSCLC.

GSK's ASCIs aim to stimulate the patient's own immune response to identify and attack cancer cells in a highly specific manner. This novel cancer immunotherapy is developed using tumor specific antigens, delivered as highly puri
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
2. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
3. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
4. Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
5. Genetic Analysis Systems Enter the Clinical Mainstream
6. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
7. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
8. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease

Post Your Comments:
(Date:11/23/2009)...Call/--AMICAS,Inc.(Nasdaq: AMCS ),aleaderinimagean...itwillhighlightitsenterpriseimagingautomationsolut...A)annualmeetingfromNovember29toDecember4inChicago,...Logo: http://www.newscom.com/cgi-bin/prnh/20060202...bouthealthcarereform,thereisanunprecedentedinteres...
(Date:11/23/2009)...r.comannouncesthatanewmarketresearchreportisavaila...orldMarketReview ,, http://www.reportlinker....et-Review.html#utm_source=prnewswire&utm_mediu...eneralanesthesiadisposablesmarketischaracterizedby...witnessedingeneralsurgicalprocedures,growingpopula...
(Date:11/23/2009)...CryoLife,Inc. (NYSE: CRY ),animplantablebiological...any,announcedtodaythatitisscheduledtoparticipatein...nceatTheNewYorkPalaceHotelonDecember1,2009. ,, ...ofCryoLife,Inc.,willprovideacorporateoverviewregar...ndanswersessionat4:30p.m.EasternTime. ,, CryoLi...
Breaking Medicine Technology:AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 2AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 3Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Almac Doubles Capacity at North Carolina Facility 61509 1Almac Doubles Capacity at North Carolina Facility 61509 2Almac Doubles Capacity at North Carolina Facility 61509 3NMB Motors Now In Stock at Newark 61507 1NMB Motors Now In Stock at Newark 61507 2Argonne Recognized for 26quot 3BGreen Computing 26quot 3B in 2009 HPCwire Readers 26apos 3B and Editors 26apos 3B Choice Awards 14872 1Argonne Recognized for 26quot 3BGreen Computing 26quot 3B in 2009 HPCwire Readers 26apos 3B and Editors 26apos 3B Choice Awards 14872 2Argonne Recognized for 26quot 3BGreen Computing 26quot 3B in 2009 HPCwire Readers 26apos 3B and Editors 26apos 3B Choice Awards 14872 3Argonne Recognized for 26quot 3BGreen Computing 26quot 3B in 2009 HPCwire Readers 26apos 3B and Editors 26apos 3B Choice Awards 14872 4
... Patient Registry Presented at TCT 2007; EVEREST I...ues, WASHINGTON, Oct. 24 The vast majority of pa...aneous MitraClip device did not need,mitral valve ...y benefited,from significantly improved function o...modeling), according to data presented this week a...
...Oct. 24 Pharmasset, Inc.,(Nasdaq: VRUS ) has rec...d,Drug Administration (FDA) for R7128 for the trea.... R7128 is a prodrug of PSI-6130, an oral cytidine...t is being developed,through Pharmasset,s collabor...g a 28-day Phase 1 clinical trial to evaluate R712...
Other Medicine Technology:New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 2New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 3New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 4New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 5R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 2R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 3R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 4R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 5
(Date:11/23/2009)...HAMPTON,N.Y.,Nov.23/PRNewswire-USNewswire/--Southa...havedonated$5milliontofundanewEmergencyDepartment....abletheHospitaltoalmostdoubletheexistingspaceandgr...dvisitorsoftheSouthForkofLongIsland. ,, Schedul...ergencyDepartment willprovideacentralizedtraumanur...
(Date:11/23/2009)... Minn. -- Major medical errors self-reported by Am...ut and depression. Those findings appear today in ...o Clinic-led study included collaborators from Joh..., In the confidential study, nearly 9 percent ... error in the three months prior to being surveyed...
(Date:11/23/2009)... Plastic and Reconstructive Surgery.....eep you updated on the most current journal news f...btain any of the full studies highlighted here, or...se contact ASPS Public Relations at (847) 228-9900... (Vocus) November 23, 2009 -- Yes, Plastic S...
(Date:11/23/2009)...ANDRIA,Va.,Nov.23/PRNewswire/--JustintimefortheTha...omechefswithtipsandrecipesforcookingupadeliciousme...tnewsandhealthinformation, turkeyfrying.net al...urkeyaswellaspartyideasfortakingtheturkeybeyondTha...ticallySouthernwayofdeep-fryingwith100%peanutoil. ...
(Date:11/23/2009)...protein changes offer clues to treatment advances,...Day News) -- The protein content of saliva changes...changes may help lead to a simple test to diagnose...st. , Human saliva contains numerous proteins t...d other functions. Researchers are trying to find ...
Breaking Medicine News(10 mins):Health News:Southampton Hospital Receives $5 Million Gift for New Emergency Department 2Health News:Burnout and mental distress strongly related to errors by US surgeons 2Health News:Plastic and Reconstructive Surgery...In Brief 2Health News:Plastic and Reconstructive Surgery...In Brief 3
...rwegian Institute of Public Health in Oslo investi...rexia nervosa, a form of eating disorder, explaine...great deal of importance to self-starvation, which...s in the patients’ lives, may not realize an absol...
...eating cancer , in which antibodies which have ra...nto patients.// These antibodies target and destr...e radioactive particles . The main advatage of thi...omeday. Ekaterina Dadachova at the Albert Einstein...
...e-winning novelist, passed away today at Martha's ...hter, Alexandra, he died of pneumonia at Martha's ... was obsessive about race, class and his own guilt...oks included "Sophie's Choice," an award-winning n...
...st man alive. He is 7 feet, 8.95 inches tall.// Th...e on November 9th. Xi will be sent to Brazil to pa... be published in the Guinness Book of Records, 200...n by profession and was born and brought up in nor...
...f deaths due to alcoholism has raised twofold in t...istics (ONS) revealed that the number of deaths du... risen to 8,386 by last year. According to the ...rinking culture among the teens, which has risen s...
...th and help doctors predict if we have any life th...s reveal eyesight abnormalities, such as macular d...el Rosen, of Rosen Eye Associates, Manchester, a t... of Daily Mail. The new eye test by an upgrad...
Other Medicine News:Health News:A New Option For AIDS Treatment - Radioimmunotherapy 2Health News:Deaths due to heavy drinking has doubled in 15 years 2Health News:Eye could reveal serious health disorder 2
...ation., ,Higher magnification for advanced sur...rue image. Edge to edge clarity and precise color ...ions. The XL's precision lenses are treated with a...age., ,Ideal for surgeons who require higher m...
VACUETTE® Tube Holders
MONOJECT Blood Collection Needle and Tube Holders
Optima III 45 Noninsulated Cobra Grasper, with ratchet
Medicine Products: